Development of Irreversible Inactivators of Spermine Oxidase and N¹-Acetylpolyamine Oxidase

  • Moriya Shun-suke
    Translational Medical Research Center, Tokyo Metropolitan Institute of Medical Science
  • Miura Toshiyuki
    Translational Medical Research Center, Tokyo Metropolitan Institute of Medical Science
  • Takao Koichi
    Faculty of Pharmaceutical Sciences, Josai University
  • Sugita Yoshiaki
    Faculty of Pharmaceutical Sciences, Josai University
  • Samejima Keijiro
    Translational Medical Research Center, Tokyo Metropolitan Institute of Medical Science
  • Hiramatsu Kyoko
    Translational Medical Research Center, Tokyo Metropolitan Institute of Medical Science
  • Kawakita Masao
    Translational Medical Research Center, Tokyo Metropolitan Institute of Medical Science

書誌事項

タイトル別名
  • Development of Irreversible Inactivators of Spermine Oxidase and <i>N</i><sup>1</sup>-Acetylpolyamine Oxidase

この論文をさがす

抄録

Three functional groups (2-propenyl, 2-propynyl, and 2,3-butadienyl) were introduced onto one of the terminal amino groups of spermidine. Of the six compounds synthesized, N-(3-aminopropyl)-N′-2,3-butadienyl-1,4-butanediamine (N8-butadienyl Spd) and N-[3-(2,3-butadienylamino)propyl]-1,4-butanediamine (N1-butadienyl Spd) irreversibly inactivated human spermine oxidase (SMO) and N1-acetylpolyamine oxidase (APAO). Interestingly, N8-butadienyl Spd inactivated SMO far more potently than N,N′-di-2,3-butadienyl-1,4-butanediamine (MDL 72527).

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (5)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ